Effects of the noradrenergic neurotoxin DSP-4 on the expression of α1-adrenoceptor subtypes after antidepressant treatment

Pharmacological Reports

Volumn 63, Issue 6, 2011, Pages 1349-1358

  Kreiner, Grzegorz ^a   Zelek Molik, Agnieszka ^a   Kowalska, Marta ^a   Bielawski, Adam ^a   Antkiewicz Michaluk, Lucyna ^a   Nalepa, Irena ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

DSP 4; Electroconvulsive shock; HPLC; Imipramine; mRNA; Northern blot

Indexed keywords

2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE; 2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1A ADRENERGIC RECEPTOR; ANTIDEPRESSANT AGENT; CITALOPRAM; IMIPRAMINE; PRAZOSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG BINDING; DRUG MECHANISM; ELECTRIC SHOCK; MALE; NEUROMODULATION; NONHUMAN; NORADRENERGIC SYSTEM; PREFRONTAL CORTEX; PROTEIN EXPRESSION; RAT; THERAPY EFFECT; TREATMENT DURATION;

EID: 84857465474     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(11)70699-5     Document Type: Article

References (39)

1. 2+channel blockade prevents lysergic acid diethylamide-induced changes in dopamine and serotonin metabolism. Eur J Pharmacol, 1997, 332, 9-14.
2. Chalothorn D, McCune DF, Edelmann SE, Garcia-Cazarin ML, Tsujimoto G, Piascik MT: Differences in the cellular localization and agonist-mediated internalization properties of the α1-adrenoceptor subtypes. Mol Pharmacol, 2002, 61, 1008-1016. (Pubitemid 34441765)
3. 1-adrenergic receptor research. Acta Pharmacol Sin, 2005, 26, 1281-1287.
4. Chomczynski P: A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques, 1993, 15, 532-534, 536-537.
5. Cryan JF, O'Leary OF, Jin SH, Friedland JC, Ouyang M, Hirsch BR, Page ME et al.: Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors. Proc Natl Acad Sci USA, 2004, 101, 8186-8191. (Pubitemid 38698075)
6. Cryan JF, Page ME, Lucki I: Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test. Eur J Pharmacol, 2002, 436, 197-205. (Pubitemid 34164699)
7. 1Areceptor in adult rats after neonatal noradrenergic neurons' lesion - Implications for antidepressant-like action. Brain Res, 2008, 1239, 66-76.
8. 1L-adrenoceptor pharmacology in functional studies. Eur J Pharmacol, 1999, 370, 337-343.
9. 1B-adrenergic receptors differentially modulate antidepressant-like behavior in the mouse. Brain Res, 2009, 1285, 148-157.
10. Duhl DM, Gillespie DD, Sulser F: Ethidium bromide fluorescence of 28S ribosomal RNA can be used to normalize samples in northern or dot blots when analyzing small drug-induced changes in specific mRNA. J Neurosci Methods, 1992, 42, 211-218.
11. 1B receptor reactivity in adult rats. Behavioral and biochemical studies. Pharmacol Rep, 2010, 62, 608-620.
12. Harro J, Pahkla R, Modiri AR, Harro M, Kask A, Oreland L: Dose-dependent effects of noradrenergic denervation by DSP-4 treatment on forced swimming and α-adrenoceptor binding in the rat. J Neural Transm, 1999, 106, 619-629. (Pubitemid 29401351)
13. 1-adrenoceptors in the frontal cortex of the rat. Neuropharmacology, 1992, 31, 955-960.
14. Heal DJ, Butler SA, Prow MR, Buckett WR: Quantification of presynaptic alpha 2-adrenoceptors in rat brain after short-term DSP-4 lesioning. Eur J Pharmacol, 1993, 249, 37-41.
15. Hughes ZA, Stanford SC: A partial noradrenergic lesion induced by DSP-4 increases extracellular noradrenaline concentration in rat frontal cortex: a microdialysis study in vivo. Psychopharmacology (Berl), 1998, 136, 299-303. (Pubitemid 28143180)
16. Itoi K, Sugimoto N: The brainstem noradrenergic systems in stress, anxiety and depression. J Neuroendocrinol, 2010, 22, 355-361.
17. Kask A, Harro J, Tuomaine P, Rago L, Mannisto PT: Overflow of noradrenaline and dopamine in frontal cortex after [N-(2-chloroethyl)-N-ethyl-2- bromobenzylamine] (DSP-4) treatment: in vivo microdialysis study in anaesthetized rats. Naunyn Schmiedebergs Arch Pharmacol, 1997, 355, 267-272. (Pubitemid 27065318)
18. 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline. Br J Pharmacol, 1995, 115, 981-986.
19. Kostrzewa RM: Evolution of neurotoxins: from research modalities to clinical realities. Curr Protoc Neurosci, 2009, Chapter 1, Unit 1. 18.
20. 1-AR) subtypes. Pol J Pharmacol, 2004, 56, 831-836.
21. 1B-adrenoceptor mRNA. Pol J Pharmacol, 2002, 54, 401-405.
22. 1A- adrenoceptor mRNA level in rat prefrontal cortex. Eur J Pharmacol, 2002, 444, 151-159.
23. Nalepa I, Sulser F: New hypothesis to guide future antidepressant drug development. Antidepressants: past, present and future. Handbook of Experimental Pharmacology, 2004, 519-563.
24. Nalepa I, Vetulani J: Enhancement of the responsiveness of cortical adrenergic receptors by chronic administration of the 5-hydroxytryptamine uptake inhibitor citalopram. J Neurochem, 1993, 60, 2029-2035. (Pubitemid 23148774)
25. Nalepa I, Vetulani J: Involvement of protein kinase C in the mechanism of in vitro effects of imipramine on generation of second messengers by noradrenaline in cerebral cortical slices of the rat. Neuroscience, 1991, 44, 585-590.
26. Nalepa I, Vetulani J: The responsiveness of cerebral cortical adrenergic receptors after chronic administration of atypical antidepressant mianserin. J Psychiatry Neurosci, 1994, 19, 120-128. (Pubitemid 24131863)
27. Nowak G, Zak J, Superata J: Role of dopaminergic neurons in denervation-induced alpha 1-adrenergic upregulation in the rat cerebral cortex. J Neurochem, 1991, 56, 914-916. (Pubitemid 21922702)
28. Perez DM: The adrenergic receptors in the 21 century. Humana Press, Totowa, New Jersey, 2006.
29. 1-Adrenergic receptors: new insights and directions. J Pharmacol Exp Ther, 2001, 298, 403-410.
30. 2-adrenoceptors which regulate the synthesis and release of noradrenaline in the rat brain. Pharmacol Toxicol, 2001, 88, 152-158.
31. 1C. J Biol Chem, 1996, 271, 5839-5843.
32. Rossby SP, Nalepa I, Huang M, Perrin C, Burt AM, Schmidt DE, Gillespie DD et al.: Norepinephrine-independent regulation of GRII mRNA in vivo by a tricyclic antidepressant. Brain Res, 1995, 687, 79-82.
33. Szot P, Miguelez C, White SS, Franklin A, Sikkema C, Wilkinson CW, Ugedo L et al.: A comprehensive analysis of the effect of DSP4 on the locus coeruleus noradrenergic system in the rat. Neuroscience, 2010, 166, 279-291.
34. Thomas DN, Nutt DJ, Holman RB: Effects of acute and chronic electroconvulsive shock on noradrenaline release in the rat hippocampus and frontal cortex. Br J Pharmacol, 1992, 106, 430-434.
35. Vetulani J, Nalepa I: Antidepressants: past, present and future. Eur J Pharmacol, 2000, 405, 351-363.
36. 7 receptor blockade on the behavioral and neurochemical effects of imipramine in rats. Pharmacol Rep, 2008, 60, 464-474.
37. Wolfman C, Abo V, Calvo D, Medina J, Dajas F, Silveira R: Recovery of central noradrenergic neurons one year after the administration of the neurotoxin DSP4. Neurochem Int, 1994, 25, 395-400.
38. 1-adrenoceptor subtypes. Naunyn Schmiedebergs Arch Pharmacol, 1999, 359, 439-446.
39. 1-Adrenoceptor subtypes. Eur J Pharmacol, 1999, 375, 261-276.